The Ocular Endothelin System: A Novel Target for the Treatment of Endotoxin-Induced Uveitis With Bosentan
dc.contributor.author | Keles, Sadullah | |
dc.contributor.author | Halici, Zekai | |
dc.contributor.author | Atmaca, Hasan Tarik | |
dc.contributor.author | Yayla, Muhammed | |
dc.contributor.author | Yildirim, Kenan | |
dc.contributor.author | Ekinci, Metin | |
dc.contributor.author | Bayraktutan, Zafer | |
dc.date.accessioned | 2020-06-25T18:12:12Z | |
dc.date.available | 2020-06-25T18:12:12Z | |
dc.date.issued | 2014 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description | Yayla, Muhammed/0000-0002-0659-3084; ATMACA, HASAN TARIK/0000-0001-8379-4114 | |
dc.description.abstract | PURPOSE. We compared the anti-inflammatory effects of bosentan and dexamethasone in endotoxin-induced uveitis (EIU). METHODS. Endotoxin-induced uveitis was induced by subcutaneous injection of lipopolysaccharide (LPS, 200 mu g) in Wistar rats. Rats were divided randomly into 10 groups (n=6). Bosentan at doses of 50 and 100 mg/kg were administered orally 1 hour before and 12 hours after LPS injection, and dexamethasone was administered by intraperitoneally 30 minutes before and 30 minutes after LPS injection at a dose of 1 mg/kg. Data were collected at two time points for each control and treatment; animals were killed at either 3 or 24 hours after LPS injection. Histopathologic evaluation and aqueous humour measurements of TNF-alpha level were performed, and endothelin-1 (ET-1), inducible nitric oxide synthase (iNOS), and endothelin receptor A and B (EDNRA and B) expression were analyzed. RESULTS. The group treated with 100 mg/kg bosentan at 24 hours displayed significantly milder uveitis and fewer inflammatory cells compared to LPS-injected animals, and there were similar findings in the dexamethasone-treated group at 24 hours. The TNF-alpha levels in the dexamethasone treatment group were lower than those in the LPS-induced uveitis control group (P < 0.05); however, there was no difference between the dexamethasone and bosentan treatment groups at 3 and 24 hours after LPS administration. Bosentan treatment at doses of 50 and 100 mg/kg significantly decreased iNOS expression compared to LPS-injected animals (P < 0.001). The ET-1 expression was suppressed significantly by bosentan and dexamethasone at 3 and 24 hours after LPS administration (P < 0.001). The EDNRA expression in the bosentan treatment groups was statistically significantly lower than that in the LPS-induced uveitis control group at 3 and 24 hours after LPS administration (P < 0.05). CONCLUSIONS. Bosentan reduces intraocular inflammation and has similar effects as dexamethasone in a rat model of EIU. | en_US |
dc.description.sponsorship | Ataturk University Scientific Experimental Project OfficeAtaturk University [2012/5] | en_US |
dc.description.sponsorship | Supported by Ataturk University Scientific Experimental Project Office to Project Number 2012/5. | en_US |
dc.identifier.citation | closedAccess | en_US |
dc.identifier.doi | 10.1167/iovs.14-14193 | |
dc.identifier.endpage | 3524 | en_US |
dc.identifier.issn | 0146-0404 | |
dc.identifier.issn | 1552-5783 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 24833743 | |
dc.identifier.scopus | 2-s2.0-84902245892 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 3517 | en_US |
dc.identifier.uri | https://doi.org/10.1167/iovs.14-14193 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/5796 | |
dc.identifier.volume | 55 | en_US |
dc.identifier.wos | WOS:000339485800020 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Assoc Research Vision Ophthalmology Inc | en_US |
dc.relation.ispartof | Investigative Ophthalmology & Visual Science | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | endotoxin-induced uveitis | en_US |
dc.subject | bosentan | en_US |
dc.subject | TNF-alpha | en_US |
dc.subject | iNOS | en_US |
dc.subject | endothelin-1 | en_US |
dc.title | The Ocular Endothelin System: A Novel Target for the Treatment of Endotoxin-Induced Uveitis With Bosentan | en_US |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
[ X ]
- İsim:
- The Ocular Endothelin System A Novel Target for the Treatment of Endotoxin-Induced Uveitis With Bosentan.pdf
- Boyut:
- 574.23 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text